Metallothionein isoform 1 and 2 gene expression in a human urothelial cell line (UROtsa) exposed to CdCl2 and NaAsO2

Donald A. Sens, Michael R. Rossi, Seongmi Park, Volkan Gurel, Joginder Nath, Scott H. Garrett, Mary Ann Sens, Seema Somji

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Studies have shown that metallothionein (MT) is overexpressed in some human bladder cancers and that overexpression can predict treatment response to neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy. In the present study the UROtsa cell line, a model of normal human urothelium, was used to determine the expression of the human MT-1 and MT-2 genes and MTprotein following exposure to CdCl2 or NaAsO2 at lethal and sublethal levels. Acute exposure was modeled by treating confluent cultures with 100 μM NaAsO2 or 53.4 μM CdCl2 for 4 h followed by a 48-h recovery period. Extended exposure was modeled by treating confluent cells with 1, 4, and 8 μM As3+ or 1, 5, and 9 μM Cd2+ for 16 d, with the highest concentrations producing cell lethality. The expression of MT mRNAs and protein were determined by reverse-transcription polymerase chain reaction (RT-PCR) and immunoblot analysis. Cell viability was determined by the MTT assay. It was shown that acute exposure to either As3+ or Cd2+ increased the levels of mRNAs for the MT-1E, MT-1X, and MT-2A genes, whereas extended exposure only increased these mRNAs following exposure to Cd2+. It was shown that both acute and extended exposure to either As3+ or Cd2+ increased the levels of MT protein, reaching a maximal value of 8 ng MT protein/μg total protein for acute exposure to Cd2+. This is in contrast to previous studies using cultured human proximal tubule cells, where similar extended treatment with Cd2+ resulted in over 20-fold higher MT protein levels. These studies demonstrate that human urothelial cells accumulate only modest amounts of MT protein when exposed to either Cd 2+ or As2+ for a 16-d time period.

Original languageEnglish (US)
Pages (from-to)2031-2046
Number of pages16
JournalJournal of Toxicology and Environmental Health - Part A
Volume66
Issue number21
StatePublished - Nov 14 2003

Fingerprint

Cadmium Chloride
metallothionein
Metallothionein
Gene expression
gene expression
Cells
Gene Expression
Cell Line
Proteins
protein
Messenger RNA
metallothionein isoform 1
Genes
chemotherapy
Urothelium
Chemotherapy
Vinblastine
exposure
gene
Polymerase chain reaction

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Public Health, Environmental and Occupational Health
  • Pollution
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Sens, D. A., Rossi, M. R., Park, S., Gurel, V., Nath, J., Garrett, S. H., ... Somji, S. (2003). Metallothionein isoform 1 and 2 gene expression in a human urothelial cell line (UROtsa) exposed to CdCl2 and NaAsO2 Journal of Toxicology and Environmental Health - Part A, 66(21), 2031-2046.

Metallothionein isoform 1 and 2 gene expression in a human urothelial cell line (UROtsa) exposed to CdCl2 and NaAsO2 . / Sens, Donald A.; Rossi, Michael R.; Park, Seongmi; Gurel, Volkan; Nath, Joginder; Garrett, Scott H.; Sens, Mary Ann; Somji, Seema.

In: Journal of Toxicology and Environmental Health - Part A, Vol. 66, No. 21, 14.11.2003, p. 2031-2046.

Research output: Contribution to journalArticle

Sens, DA, Rossi, MR, Park, S, Gurel, V, Nath, J, Garrett, SH, Sens, MA & Somji, S 2003, 'Metallothionein isoform 1 and 2 gene expression in a human urothelial cell line (UROtsa) exposed to CdCl2 and NaAsO2 ', Journal of Toxicology and Environmental Health - Part A, vol. 66, no. 21, pp. 2031-2046.
Sens, Donald A. ; Rossi, Michael R. ; Park, Seongmi ; Gurel, Volkan ; Nath, Joginder ; Garrett, Scott H. ; Sens, Mary Ann ; Somji, Seema. / Metallothionein isoform 1 and 2 gene expression in a human urothelial cell line (UROtsa) exposed to CdCl2 and NaAsO2 In: Journal of Toxicology and Environmental Health - Part A. 2003 ; Vol. 66, No. 21. pp. 2031-2046.
@article{d5de301891be4781a264a53f70044eff,
title = "Metallothionein isoform 1 and 2 gene expression in a human urothelial cell line (UROtsa) exposed to CdCl2 and NaAsO2",
abstract = "Studies have shown that metallothionein (MT) is overexpressed in some human bladder cancers and that overexpression can predict treatment response to neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy. In the present study the UROtsa cell line, a model of normal human urothelium, was used to determine the expression of the human MT-1 and MT-2 genes and MTprotein following exposure to CdCl2 or NaAsO2 at lethal and sublethal levels. Acute exposure was modeled by treating confluent cultures with 100 μM NaAsO2 or 53.4 μM CdCl2 for 4 h followed by a 48-h recovery period. Extended exposure was modeled by treating confluent cells with 1, 4, and 8 μM As3+ or 1, 5, and 9 μM Cd2+ for 16 d, with the highest concentrations producing cell lethality. The expression of MT mRNAs and protein were determined by reverse-transcription polymerase chain reaction (RT-PCR) and immunoblot analysis. Cell viability was determined by the MTT assay. It was shown that acute exposure to either As3+ or Cd2+ increased the levels of mRNAs for the MT-1E, MT-1X, and MT-2A genes, whereas extended exposure only increased these mRNAs following exposure to Cd2+. It was shown that both acute and extended exposure to either As3+ or Cd2+ increased the levels of MT protein, reaching a maximal value of 8 ng MT protein/μg total protein for acute exposure to Cd2+. This is in contrast to previous studies using cultured human proximal tubule cells, where similar extended treatment with Cd2+ resulted in over 20-fold higher MT protein levels. These studies demonstrate that human urothelial cells accumulate only modest amounts of MT protein when exposed to either Cd 2+ or As2+ for a 16-d time period.",
author = "Sens, {Donald A.} and Rossi, {Michael R.} and Seongmi Park and Volkan Gurel and Joginder Nath and Garrett, {Scott H.} and Sens, {Mary Ann} and Seema Somji",
year = "2003",
month = "11",
day = "14",
language = "English (US)",
volume = "66",
pages = "2031--2046",
journal = "Journal of Toxicology and Environmental Health - Part A: Current Issues",
issn = "1528-7394",
publisher = "Taylor and Francis Ltd.",
number = "21",

}

TY - JOUR

T1 - Metallothionein isoform 1 and 2 gene expression in a human urothelial cell line (UROtsa) exposed to CdCl2 and NaAsO2

AU - Sens, Donald A.

AU - Rossi, Michael R.

AU - Park, Seongmi

AU - Gurel, Volkan

AU - Nath, Joginder

AU - Garrett, Scott H.

AU - Sens, Mary Ann

AU - Somji, Seema

PY - 2003/11/14

Y1 - 2003/11/14

N2 - Studies have shown that metallothionein (MT) is overexpressed in some human bladder cancers and that overexpression can predict treatment response to neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy. In the present study the UROtsa cell line, a model of normal human urothelium, was used to determine the expression of the human MT-1 and MT-2 genes and MTprotein following exposure to CdCl2 or NaAsO2 at lethal and sublethal levels. Acute exposure was modeled by treating confluent cultures with 100 μM NaAsO2 or 53.4 μM CdCl2 for 4 h followed by a 48-h recovery period. Extended exposure was modeled by treating confluent cells with 1, 4, and 8 μM As3+ or 1, 5, and 9 μM Cd2+ for 16 d, with the highest concentrations producing cell lethality. The expression of MT mRNAs and protein were determined by reverse-transcription polymerase chain reaction (RT-PCR) and immunoblot analysis. Cell viability was determined by the MTT assay. It was shown that acute exposure to either As3+ or Cd2+ increased the levels of mRNAs for the MT-1E, MT-1X, and MT-2A genes, whereas extended exposure only increased these mRNAs following exposure to Cd2+. It was shown that both acute and extended exposure to either As3+ or Cd2+ increased the levels of MT protein, reaching a maximal value of 8 ng MT protein/μg total protein for acute exposure to Cd2+. This is in contrast to previous studies using cultured human proximal tubule cells, where similar extended treatment with Cd2+ resulted in over 20-fold higher MT protein levels. These studies demonstrate that human urothelial cells accumulate only modest amounts of MT protein when exposed to either Cd 2+ or As2+ for a 16-d time period.

AB - Studies have shown that metallothionein (MT) is overexpressed in some human bladder cancers and that overexpression can predict treatment response to neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy. In the present study the UROtsa cell line, a model of normal human urothelium, was used to determine the expression of the human MT-1 and MT-2 genes and MTprotein following exposure to CdCl2 or NaAsO2 at lethal and sublethal levels. Acute exposure was modeled by treating confluent cultures with 100 μM NaAsO2 or 53.4 μM CdCl2 for 4 h followed by a 48-h recovery period. Extended exposure was modeled by treating confluent cells with 1, 4, and 8 μM As3+ or 1, 5, and 9 μM Cd2+ for 16 d, with the highest concentrations producing cell lethality. The expression of MT mRNAs and protein were determined by reverse-transcription polymerase chain reaction (RT-PCR) and immunoblot analysis. Cell viability was determined by the MTT assay. It was shown that acute exposure to either As3+ or Cd2+ increased the levels of mRNAs for the MT-1E, MT-1X, and MT-2A genes, whereas extended exposure only increased these mRNAs following exposure to Cd2+. It was shown that both acute and extended exposure to either As3+ or Cd2+ increased the levels of MT protein, reaching a maximal value of 8 ng MT protein/μg total protein for acute exposure to Cd2+. This is in contrast to previous studies using cultured human proximal tubule cells, where similar extended treatment with Cd2+ resulted in over 20-fold higher MT protein levels. These studies demonstrate that human urothelial cells accumulate only modest amounts of MT protein when exposed to either Cd 2+ or As2+ for a 16-d time period.

UR - http://www.scopus.com/inward/record.url?scp=0242288469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242288469&partnerID=8YFLogxK

M3 - Article

VL - 66

SP - 2031

EP - 2046

JO - Journal of Toxicology and Environmental Health - Part A: Current Issues

JF - Journal of Toxicology and Environmental Health - Part A: Current Issues

SN - 1528-7394

IS - 21

ER -